US and Canada to roll out the first omicron specific boosters within days
BMJ : British Medical Journal (Online)
; 378, 2022.
Article
in English
| ProQuest Central | ID: covidwho-2020004
ABSTRACT
The Food and Drug Administration (FDA) authorised updated boosters from Pfizer BioNTech and from Moderna on 31 August, and an expert advisory committee convened the next day by the Centers for Disease Control and Prevention (CDC) voted 13-1 to recommend their use. A projection shown to the experts estimated that waiting to roll out the new boosters until November, when more human data will be available could have resulted in 9700 more deaths and 137 000 more hospital admissions.1 Canada approves older omicron booster Health Canada on 1 September approved for adults Moderna’s bivalent booster that targets the omicron BA.1 variant. BA.1 disappeared from circulation in May, but Canada’s National Advisory Committee on Immunization said the new booster will generate a significantly more effective neutralising antibody response against BA.4 and BA.5 than the original Moderna vaccine.
Full text:
Available
Collection:
Databases of international organizations
Database:
ProQuest Central
Topics:
Vaccines
/
Variants
Language:
English
Journal:
BMJ : British Medical Journal (Online)
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS